摘要
目的:探讨初诊初治时中性粒细胞/淋巴细胞比值(NLR)对原发性血小板增多症(ET)患者血栓事件发生和进展的影响及临床意义。方法:回顾性分析150例原发性血小板增多症患者临床和随访资料,用统计学方法分析血栓事件的危险因素。结果:年龄(P=0.001)和JAK2V617F突变(P=0.003)是诊断时血栓事件独立危险因素;年龄(P=0.037)、NLR(P<0.001)、WBC计数(P=0.047)及初诊时血栓病史(P=0.036)是随访过程中未来血栓事件进展的独立危险因素;ROC WBC计数以及初诊时血栓病史。Kaplan-Meier生存分析表明,高NLR组血栓事件无进展生存时间(中位生存时间22.3个月, 95%CI:17.8-26.8)明显低于低NLR组(中位生存时间55.5个月, 95%CI:53.4-57.5)。低NLR组60个月血栓事件无进展生存率为97.4%,而高NLR组60个月血栓事件无进展生存率为46.7%。结论:ET患者初诊初治时外周血NLR水平较传统临床指标对未来血栓事件进展具有更好的诊断预测价值,但与诊断时已经发生的血栓事件没有明显相关性。
Objective:To explore the role of neutrophil-to-lymphocyte ratio(NLR)in patients with newly diagnosed essential thrombocythemia(ET)and its relationship with thrombotic events.Methods:The clinical and follow-up data of 150 ET patients were retrospectively analyzed.The risk factors of thrombotic events and role of NLR by statistical methods.Results:Age(P<0.01)and JAK2V617F mutation(P<0.01)were the independent risk factors for thrombotic events at diagnosis;WBC count(P<0.05),NLR(P<0.01),age(P<0.05)and thrombosis history at diagnosis(P<0.05)were independent risk factors for future thrombotic events.The ROC curve showed that NLR for prediction of future thrombotic events was suprior to other risk factors.The Kaplan-Meier analysis showed that the progress-free survival time in thrombotic events patients with higher NLR(median survival 22.3 months,95% CI:17.8-26.8)was significantly shorter than that of patients with lower NLR(median survival 55.5 months,95% CI:53.4-57.5).After follow-up 60 months,the thrombosis progress-free survival in lower NLR patients reached 97.4%,while that in the patients with higher NLR was rate 46.7%.Conclusion:NLR at diagnosis is a better predictive parameter for future thrombotic events than other clinical parameters in ET patients,but without corralations with thrombosis at diagnosis.
作者
周典
程海
陈伟
李振宇
徐开林
ZHOU Dian;CHENG Hai;CHEN Wei;LI Zhen-Yu;XU Kai-Lin(Institute of Hematology,Xuzhou Medical University;Department of Hematology,The Affiliated Hospital of Xuzhou Medical University,Xuzhou 221002,Jiangsu Province,China)
出处
《中国实验血液学杂志》
CAS
CSCD
北大核心
2019年第2期534-538,共5页
Journal of Experimental Hematology
基金
国家自然科学基金青年基金(81500097)
江苏省高校自然科学基金(15KJB320016)
关键词
粒淋比
血栓
原发性血小板增多症
neutrophil-to-lymphocyte ratio
thrombotic event
essential thrombocythemia